|[February 15, 2013]
Research and Markets: The Corporate Reputation of Pharma in 2012 - the Patient Perspective Featuring 29 Individual Pharma Companies
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/jdj75c/the_corporate)
has announced the addition of the "The
Corporate Reputation of Pharma in 2012the Patient Perspective"
report to their offering.
A global survey of the views of 600 international, national, and
regional patient groups on the corporate reputation of the pharma
industry and 29 leading pharma companies
Increasing numbers of pharmaceutical companies are seeking to redefine
their relationships with patients, recasting their companies as more
Key findings industry-wide; reputation of pharma fell in 2012
The overall reputation of pharma declined in 2012. Only 34% of the 600
patient groups responding to the 2012 survey state that multinational
pharma companies had an Excllent or Good reputation during 2012. The
equivalent figure from the 500 patient groups responding to the 2011
survey was 42%. 40% of the 600 respondent patient groups state that the
reputation of the pharma industry had declined during 2012. As many as
50% of the 600 respondent patient groups say that industry had a Poor
record in 2012 for having fair pricing policies. 48% of the 600
respondent patient groups say that industry had a Poor record in 2012
for being transparent. When the 2012 results are compared with those of
2011, the sharpest falls in pharma performance are for the following:
- Managing adverse news about products a 29% fall between 2011 and 2012.
- Having ethical marketing practices a 23% fall between 2011 and 2012.
- Having a good relationship with the media a 19% fall, 2011-2012.
Several reasons explain why pharma's reputation fell during 2012
- Baxter International
- Biogen Idec
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eli Lilly (Lilly)
- Gilead Sciences
- GlaxoSmithKline (GSK)
- Merck & Co (the US company)
- Merck Group (the German company)
- Novo Nordisk
- Stada Arzneimittel
For more information visit http://www.researchandmarkets.com/research/jdj75c/the_corporate
[ Back To Technology News's Homepage ]